BioHarvest Sciences Inc.
BHST
$4.21
-$0.04-0.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.07M | 9.07M | 8.52M | 7.86M | 7.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.07M | 9.07M | 8.52M | 7.86M | 7.28M |
| Cost of Revenue | 3.84M | 3.50M | 3.43M | 3.27M | 3.16M |
| Gross Profit | 5.23M | 5.57M | 5.09M | 4.60M | 4.12M |
| SG&A Expenses | 5.05M | 5.06M | 5.56M | 5.07M | 4.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.19M | 9.99M | 10.33M | 9.58M | 8.97M |
| Operating Income | -1.12M | -920.00K | -1.82M | -1.72M | -1.69M |
| Income Before Tax | -2.27M | -2.45M | -4.04M | -2.30M | -2.95M |
| Income Tax Expenses | -64.00K | 63.00K | 39.00K | 38.00K | 8.00K |
| Earnings from Continuing Operations | -2.20M | -2.51M | -4.08M | -2.34M | -2.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.20M | -2.51M | -4.08M | -2.34M | -2.96M |
| EBIT | -1.12M | -920.00K | -1.82M | -1.72M | -1.69M |
| EBITDA | -1.01M | -535.00K | -1.41M | -1.32M | -1.57M |
| EPS Basic | -0.10 | -0.14 | -0.24 | -0.13 | -0.17 |
| Normalized Basic EPS | -0.07 | -0.09 | -0.15 | -0.08 | -0.11 |
| EPS Diluted | -0.10 | -0.14 | -0.24 | -0.13 | -0.17 |
| Normalized Diluted EPS | -0.07 | -0.09 | -0.15 | -0.08 | -0.11 |
| Average Basic Shares Outstanding | 21.38M | 17.42M | 17.33M | 17.33M | 17.34M |
| Average Diluted Shares Outstanding | 21.38M | 17.42M | 17.33M | 17.33M | 17.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |